COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore.

Zewen ZhangNur Diana Binte IshakFrances Victoria Fajardo QueZi Yang ChuaSock Hoai ChanJianbang ChiangJoanne Ngeow Yuen Yie

Published in: Hereditary cancer in clinical practice (2023)

The post-vaccination side effects profile among individuals with germline PV/LPV in BRCA1/2 is consistent with the Singaporean general population, hence recommendations for COVID-19 vaccination for these individuals should not differ from non-carriers and should be encouraged by their healthcare providers.

Keyphrases

coronavirus disease
sars cov
healthcare
dna repair
breast cancer risk
respiratory syndrome coronavirus
clinical practice
oxidative stress
dna damage